However, interestingly, induction of PKD1 in vivo by Dox provided a slight growth advantage to the HNSCC tumor xenografts and resulted in a significant increase in final tumor weight in Dox-induced vs the non-induced tumors. The gene discussed is PKD1; the disease is head and neck squamous cell carcinoma.